DOCSLIB.ORG

CIRCUPOSIT NEUTRALIZER 3313.Pdf

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CIRCUPOSIT NEUTRALIZER 3313.Pdf { error: graphic file not found: C:\Program Files (x86)\SAP\FrontEnd\sa pgui\WWI\graphics\Dow R.bmp } SAFETY DATA SHEET ROHM AND HAAS ELECTRONIC MATERIALS LLC Product name: CIRCUPOSIT™ NEUTRALIZER 3313 Issue Date: 01/31/2019 Print Date: 09/19/2019 ROHM AND HAAS ELECTRONIC MATERIALS LLC encourages and expects you to read and understand the entire (M)SDS, as there is important information throughout the document. We expect you to follow the precautions identified in this document unless your use conditions would necessitate other appropriate methods or actions. 1. IDENTIFICATION Product name: CIRCUPOSIT™ NEUTRALIZER 3313 Recommended use of the chemical and restrictions on use Identified uses: For industrial use: use in metal plating in circuit boards, connectors and metal finishing Uses advised against: We recommend that you use this product in a manner consistent with the listed use. If your intended use is not consistent with the stated use, please contact your sales or technical service representative. COMPANY IDENTIFICATION ROHM AND HAAS ELECTRONIC MATERIALS LLC A Subsidiary of The Dow Chemical Company 455 FOREST STREET MARLBOROUGH MA 01752 UNITED STATES Customer Information Number: 833-338-7668 [email protected] EMERGENCY TELEPHONE NUMBER 24-Hour Emergency Contact: 1 800 424 9300 Local Emergency Contact: 800-424-9300 2. HAZARDS IDENTIFICATION Hazard classification GHS classification in accordance with 29 CFR 1910.1200 Corrosive to metals - Category 1 Skin corrosion - Category 1B Serious eye damage - Category 1 Skin sensitisation - Category 1 Carcinogenicity - Category 2 Specific target organ toxicity - single exposure - Category 3 Specific target organ toxicity - repeated exposure - Category 2 - Inhalation Short-term (acute) aquatic hazard - Category 2 Label elements Hazard pictograms ® ™ Trademark of The Dow Chemical Company ("Dow") or an affiliated Page 1 of 14 company of Dow Product name: CIRCUPOSIT™ NEUTRALIZER 3313 Issue Date: 01/31/2019 Signal word: DANGER! Hazards May be corrosive to metals. Causes severe skin burns and eye damage. May cause an allergic skin reaction. May cause respiratory irritation. Suspected of causing cancer. May cause damage to organs (Eyes, Skin, Respiratory system, Blood) through prolonged or repeated exposure if inhaled. Toxic to aquatic life. Precautionary statements Prevention Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Keep only in original container. Do not breathe dust/ fume/ gas/ mist/ vapours/ spray. Wash skin thoroughly after handling. Use only outdoors or in a well-ventilated area. Contaminated work clothing should not be allowed out of the workplace. Avoid release to the environment. Wear protective gloves/ protective clothing/ eye protection/ face protection. Response IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water/shower. IF INHALED: Remove person to fresh air and keep comfortable for breathing. Immediately call a POISON CENTER/doctor. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Immediately call a POISON CENTER/doctor. IF exposed or concerned: Get medical advice/ attention. If skin irritation or rash occurs: Get medical advice/ attention. Wash contaminated clothing before reuse. Absorb spillage to prevent material damage. Storage Store in a well-ventilated place. Keep container tightly closed. Store locked up. Store in corrosive resistant container with a resistant inner liner. Disposal Dispose of contents/ container to an approved waste disposal plant. Other hazards Page 2 of 14 Product name: CIRCUPOSIT™ NEUTRALIZER 3313 Issue Date: 01/31/2019 No data available 3. COMPOSITION/INFORMATION ON INGREDIENTS Chemical nature: Aqueous solution of organic and inorganic compounds This product is a mixture. Component CASRN Concentration Water 7732-18-5 65.0 - 75.0 % Methane sulfonic acid 75-75-2 20.0 - 30.0 % Amino nitrate salt 1.0 - 10.0 % Non-ionic surfactant 1.0 - 10.0 % 4. FIRST AID MEASURES Description of first aid measures Inhalation: Remove from exposure. If there is difficulty in breathing, give oxygen. Immediate medical attention is required. Skin contact: Immediately flush the skin with large quantitiesof water, preferably under a shower. If skin contact occurs, remove contaminated clothing and wash skin thoroughly. Continue washing for at least 20 minutes. Contaminated clothing should be washed or dry- cleaned before re-use. Immediate medical attention is required. Eye contact: Immediately flush the eye with plenty of water for at least 20 minutes, holding the eye open. Immediate medical attention is required. Ingestion: Do NOT induce vomiting. Wash out mouth with water. Have victim drink 1-3 glasses of water to dilute stomach contents. Immediate medical attention is required. Never administer anything by mouth if a victim is losing consciousness, is unconscious or is convulsing. Most important symptoms and effects, both acute and delayed: Aside from the information found under Description of first aid measures (above) and Indication of immediate medical attention and special treatment needed (below), any additional important symptoms and effects are described in Section 11: Toxicology Information. Indication of any immediate medical attention and special treatment needed Notes to physician: Treat symptomatically. Treat skin burns conventionally. 5. FIREFIGHTING MEASURES Suitable extinguishing media: Use water spray, foam, dry chemical or carbon dioxide. Page 3 of 14 Product name: CIRCUPOSIT™ NEUTRALIZER 3313 Issue Date: 01/31/2019 Unsuitable extinguishing media: None known. Special hazards arising from the substance or mixture Hazardous combustion products: Fire conditions may cause this product to decompose. Refer to section 10 - Thermal Decomposition. Unusual Fire and Explosion Hazards: This product may give rise to hazardous vapors in a fire. Advice for firefighters Fire Fighting Procedures: Keep people away. Isolate fire and deny unnecessary entry. Special protective equipment for firefighters: Wear full protective clothing and self-contained breathing apparatus. 6. ACCIDENTAL RELEASE MEASURES Personal precautions, protective equipment and emergency procedures: Wear suitable protective clothing. Wear respiratory protection. Environmental precautions: Prevent the material from entering drains or water courses. Do not discharge directly to a water source. Advise Authorities if spillage has entered watercourse or sewer or has contaminated soil or vegetation. Methods and materials for containment and cleaning up: Spills may be absorbed with appropriate absorbent material for acid solutions. Transfer into suitable containers for recovery or disposal. 7. HANDLING AND STORAGE Precautions for safe handling: Use local exhaust ventilation. Avoid contact with eyes, skin and clothing. Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Avoid breathing vapor. Keep container tightly closed. Conditions for safe storage: Store in original container. Storage area should be: cool dry well ventilated out of direct sunlight away from incompatible materials Practice good personal hygiene to prevent accidental exposure. 8. EXPOSURE CONTROLS/PERSONAL PROTECTION Control parameters If exposure limits exist, they are listed below. If no exposure limits are displayed, then no values are applicable. Component Regulation Type of listing Value/Notation Methane sulfonic acid Dow IHG TWA 1 mg/m3 Dow IHG STEL 2 mg/m3 Exposure controls Engineering controls: Engineering methods to prevent or control exposure are preferred. Methods include process or personnel enclosure, mechanical ventilation (local exhaust), and control of process conditions. Page 4 of 14 Product name: CIRCUPOSIT™ NEUTRALIZER 3313 Issue Date: 01/31/2019 Individual protection measures Eye/face protection: If there is a potential for exposure or contact to the chemical, wear following approved PPE: Chemical goggles and face shield. Skin protection Hand protection: If there is a potential for exposure or contact to the chemical, wear following approved PPE: Neoprene gloves. Other chemical resistant glovesmay be recommended by your safety professional. Gauntlet sleeves. Other protection: If there is a potential for exposure or contact to the chemical, wear following approved PPE: rubber or neoprene apron Respiratory protection: Respiratory protection if there is a risk of exposure to high vapor concentrations. The specific respirator selected must be based on the airborne concentration found in the workplace and must not exceed the working limits of the respirator. 9. PHYSICAL AND CHEMICAL PROPERTIES Appearance Physical state liquid Color Yellow to amber Odor Odorless Odor Threshold No data available pH <1 Melting point/range No data available Freezing point No data available Boiling point (760 mmHg) 100 °C ( 212 °F) Flash point Nonflammable Evaporation Rate (Butyl Acetate Not applicable = 1) Flammability (solid, gas) Not Applicable Lower explosion limit Not applicable Upper explosion limit Not applicable Vapor Pressure Not applicable Relative Vapor Density (air = 1) Not applicable Relative Density (water = 1) 1.22 Water solubility completely soluble Partition coefficient: n- No data available octanol/water Auto-ignition temperature No data available Decomposition temperature No data available Kinematic Viscosity No data available
Load more

Recommended publications
  • View/Download
    Solutions for Affordable Rental Housing in the Delaware Valley r-- - 0 0 0 DDD DDD /-""" D D •• DELAWARE VALLEY' REGIONAL PLANNING COMMISSION va August 1994 The preparation of this report was funded through federal grants from the U. S. Department of Transportation's Federal Highway Administration (FHW A) and Federal Transit Administration (FTA), the Pennsylvania and New Jersey Departments of Transportation as well as by DVRPC's state and local member governments. The authors, however, are solely responsible for its [mdings and conclusions, which may not represent the official views or policies of the funding agencies. Created in 1965, the Delaware Valley Regional Planning Commission (DVRPC) is an interstate, intercounty and intercity agency which provides continuing, comprehensive and coordinated planning for the orderly growth and development of the Delaware Valley region. The region includes Bucks, Chester, Delaware, and Montgomery counties as well as the City of Philadelphia in Pennsylvania and Burlington, Camden, Gloucester, and Mercer counties in New Jersey. The Commission is an advisory agency which divides its planning and service functions between the Office of the Executive Director, the Office of Public Affairs, and three line Divisions: Transportation Planning, Regional Planning, and Administration. DVRPC's mission for the 1990s is to emphasize technical assistance and services and to conduct high priority studies for member state and local governments, while determining and meeting the needs of the private sector. The DVRPC logo is adapted from the official seal of the Commission and is designed as a stylized image of the Delaware Valley. The outer ring symbolizes the region as a whole while the diagonal bar signifies the Delaware River flowing through it.
    [Show full text]
  • The Korn/Ferry Market Cap 100 Board Leadership at America’S Most Valuable Public Companies About the 2010 Korn/Ferry Market Cap 100
    The Korn/Ferry Market Cap 100 Board leadership at America’s most valuable public companies About the 2010 Korn/Ferry Market Cap 100 The Korn/Ferry Market Cap 100 (KFMC100) comprises the U.S. companies traded on the NYSE or NASDAQ , excluding public investment firms, with the largest market capitalization as of the close of market on May 3, 2010, after reporting for the 2009 fiscal year. Data about the companies’ boards, compiled from proxies related to fiscal year 2009, provide the baseline for this report. B Contents Introduction . 2 Board leadership in an era of change . 4 What’s in a name? . 4 Portrait of a lead director . 6 Interview with Mark Ketchum . 8 Lead director, Kraft Foods Adding value to the board . 12 Interview with Irv Hockaday . 14 Presiding director, Ford Motor Co. and Estée Lauder Companies Inc. Committee membership and leadership . 16 Leadership succession on the board . 18 Assessing the need for terms . 19 Interview with Bonnie G. Hill . 20 Lead director, The Home Depot, Inc. Compensating for time and value . 22 Final thoughts and best practices . 24 Appendix A . 25 Board data Appendix B . 32 List of the KFMC100 companies Appendix C . 35 List of the KFMC100 non-executive board leaders Introducing the Korn/Ferry Market Cap 100 The Korn/Ferry Market Cap 100 (KFMC100) marks a new approach to the governance research our firm has undertaken for thirty-five years. We’ve chosen to examine the United States’ one hundred most valuable compa- nies, working from the assumption that leadership models represented on these boards are worth observing and emulating.
    [Show full text]
  • QUAKER CHEMICAL CORPORATION (Exact Name of Registrant As Specified in Its Charter)
    UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 January 30, 2013 Date of Report (Date of earliest event reported) QUAKER CHEMICAL CORPORATION (Exact name of Registrant as specified in its charter) Commission File Number 001-12019 PENNSYLVANIA No. 23-0993790 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) One Quaker Park 901 E. Hector Street Conshohocken, Pennsylvania 19428 (Address of principal executive offices) (Zip Code) (610) 832-4000 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) INFORMATION TO BE INCLUDED IN THE REPORT Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 30, 2013, the Board of Directors (the "Board") of Quaker Chemical Corporation (the "Company") decided to temporarily increase the size of the Board from nine to ten and appointed Mark A.
    [Show full text]
  • Strategies for Talent Management
    STRATEGIES FOR TALENT MANAGEMENT: Greater Philadelphia Companies in Action August 2008 Prepared by the CEO Council for Growth in partnership with the Council for Adult and Experiential Learning Dear Regional Business Leader: On behalf of Mark S. Schweiker, Chairman of the CEO Council for Growth (CEO Council) – a tri-state, eleven county business leadership group – we are excited to present the following report, entitled “Strategies for Talent Management: Greater Philadelphia Companies in Action.” The research provides insights into some of the successful ways organizations are developing their talent and how others can strengthen their current talent management efforts. It focuses on talent management strategies as well as one specific tactic – tuition assistance programs. Human capital is clearly one of the critical issues that impacts the Greater Philadelphia region’s ability to grow and prosper. The CEO Council is committed to ensuring a steady and talented supply of quality workers for this region. While this report is focused on that later part of the talent continuum, we understand that quality early childhood and K-12 education is a key part of the foundation for our region’s success. In June of 2006, the CEO Council’s Human Capital Working Group released the final report of its Human Capital Needs Assessment. In it you indicated that the following were your two biggest challenges: 1. Hiring highly skilled and experienced mid-level professionals/managers; and 2. Recruiting diverse employees. As a natural progression from the survey, the Human Capital Working Group commissioned the Council for Adult and Experiential Learning (CAEL) in partnership with CEO Council staff to complete the research contained in this report.
    [Show full text]
  • ROHM and HAAS COMPANY 2003 Financial Report and 10K
    ROHM AND HAAS COMPANY 2003 financial report and 10k UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2003 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-3507 ROHM AND HAAS COMPANY (Exact name of registrant as specified in its charter) DELAWARE 23-1028370 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) 100 INDEPENDENCE MALL WEST, PHILADELPHIA, PA 19106 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 215-592-3000 Securities registered pursuant to Section 12(b) of the Act: Name of Each Exchange on Title of Each Class Which Registered Common Stock of $2.50 par value New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: NONE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months, and (2) has been subject to such filing requirements for the past 90 days. Yes X No . Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporat- ed by reference in Part III of this Form 10-K or any amendment to this Form 10-K X .
    [Show full text]
  • Case No COMP/M.5424 - DOW / ROHM and HAAS
    EN Case No COMP/M.5424 - DOW / ROHM AND HAAS Only the English text is available and authentic. REGULATION (EC) No 139/2004 MERGER PROCEDURE Article 6(1)(b) NON-OPPOSITION Date: 08/01/2009 In electronic form on the EUR-Lex website under document number 32009M5424 Office for Official Publications of the European Communities L-2985 Luxembourg COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 08.01.2009 SG-Greffe(2009) D/52 In the published version of this decision, some C(2009) 77 information has been omitted pursuant to Article 17(2) of Council Regulation (EC) No 139/2004 PUBLIC VERSION concerning non-disclosure of business secrets and other confidential information. The omissions are shown thus […]. Where possible the information MERGER PROCEDURE omitted has been replaced by ranges of figures or a ARTICLE 6(1)(b) DECISION general description. To the notifying party: Dear Sir/Madam, Subject: Case No COMP/M.5424 – DOW/ ROHM AND HAAS Notification of 24 November 2008 pursuant to Article 4 of Council Regulation No 139/20041 1. On 24 November 2008, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (‘the EC Merger Regulation’) by which the undertaking The Dow Chemical Company (‘Dow’, United States of America) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Rohm and Haas Company (‘R&H’, United States of America) by way of purchase of shares.2 I. THE PARTIES 2. Dow is a diversified chemicals company headquartered in the United States of America and is the ultimate parent company of the Dow group of companies, which is active in plastics and chemicals, agricultural sciences, and hydrocarbon and energy products and services.
    [Show full text]
  • Amerigas Partners, L.P. 2013 Annual Report
    AmeriGas Partners, L.P. 2013 Annual Report Driving Every Day Our vision will span the country while our service goes door to door. Driving Every Day From the desk to the dashboard from the office to the road It is what we see from our stores. This is what we do. It is who we are. We are providers. Just like our customers. AmeriGas Partners, L.P. is a publicly traded master limited AmeriGas distributes nearly 1.4 billion gallons of propane partnership that operates the nation’s largest retail propane annually to over 2 million residential, commercial/industrial, distribution business. The common units of AmeriGas motor fuel, agricultural and wholesale customers in all Partners, L.P. are traded on the New York Stock Exchange 50 states. Through the Partnership’s AmeriGas Cylinder under the symbol “APU.” UGI Corporation, through Exchange “ACE” program, ACE cylinders are available at subsidiaries, is the sole General Partner and owns 26% nearly 47,500 retail locations throughout the United States. of the Partnership. An affiliate of Energy Transfer Partners, AmeriGas operates over 2,500 distribution locations and L.P. owns 24% of the Partnership and the public owns the has nearly 8,500 dedicated employees focused on fulfilling remaining 50%. AmeriGas’ commitment to be the most reliable, safest and As a clean versatile energy source, propane is used for a most responsive propane company in the nation. wide variety of applications. Residential and commercial customers use propane for space heating, water heating, cooking and drying while industrial customers use it to fire furnaces, as a cutting gas and in other process applications.
    [Show full text]
  • November 1416, 2005 Mr. Ken Alston Chief of Staff MBDC 700 East
    SUSTAINABLE BUSINESS AND SAFER CHEMISTRY THROUGH THE SUPPLY CHAIN: AN INNOVATOR’S ROUNDTABLE November 14­16, 2005 PARTICIPANT LIST Mr. Ken Alston Mr. Jay Bolus Chief of Staff EVP, Benchmarking & Certification MBDC MBDC 700 East Jefferson, Third Floor 700 East Jefferson, Third Floor Charlottesville, VA 22902 Charlottesville, VA 22902 Phone: (434) 825­1589 Phone: (434) 295­1111 Email: [email protected] Email: [email protected] Mr. Paul Anastas Mr. David Bott Director Consultant to the Innovation Group of the DTI Green Chemistry Institute EotR Solutions Ltd., Nanomagnetics Ltd., Oxford 1155 Sixteenth St, NW Biomaterials Ltd. Washington, DC 20036 The High House Phone: (202) 872­4078 High Street Email: [email protected] Inkberrow, Worcesteshire WR7 4DT United Kingdom Mr. Tod Arbogast Phone: +44­1386­793040 Dell Sustainable Business Email: david@eotr­solutions.com Dell Inc. One Dell Way, Mailstop 8022 Mr. Troy Brantley Round Rock, TX 78682 Manager of Regulatory Compliance Phone: (512) 723­0174 Alphagary Corporation Email: [email protected] 9635 Industrial Drive PO Box 490 Mr. Geoff Archer Pineville, NC 28134 Doctoral Student Phone: (704) 889­7821 x.3207 Darden School Email: [email protected] 4835 Mechums River Rd. Charlottesville, VA 22901 Mr. Richard Brownlee Phone: (415) 516­8669 Professor Email: [email protected] Darden School 100 Darden Blvd. Mr. Steve Bradfield Charlottesville, VA 22906 Director of Environmental Affairs Phone: (434) 924­4800 Shaw Industries Email: [email protected] PO Drawer 2128 Dalton, GA 30722 Phone: (706) 275­5219 Email: [email protected] Mr. Mark Buczek Mr. Raymond Dimmock V.P. Advocacy & Regulatory Affairs Green Engine Manager Supresta Pratt & Whitney 420 Saw Mill River Road 400 Main Street Arsdley, NY 10502 M.S 162­20 Phone: (914) 264­5989 East Hartford, CT 06108 Email: [email protected] Phone: (860) 565­9635 Email: [email protected] Mr.
    [Show full text]
  • Job Title Employer A.C. Baugher Professor of Chemistry Emeritus Elizabethtown College Account Executive PHT Corp
    Chemistry Majors at F&M - Historical Data of Graduates, 1945 - present Job Title Employer A.C. Baugher Professor of Chemistry Emeritus Elizabethtown College Account Executive PHT Corp. Adjunct Faculty Eastern Michigan University Air Pollution Research Specialist Cal Air Resources Board Alumni Distinguished Professor of Chemistry & Biochemistry University of Delaware Analytical Lab Technician Blue Marsh Labs Anesthesia Resident University of Pittsburgh Anesthesiologist Anesthesia Assoc of Lancaster Anesthesiologist Fairfax Hospital Anesthesiologist Reading Anesthesia Associates Anesthesiologist Suburban Hospital Anesthesiologist Trinity Pediatric Center Anesthesiologist/Sr Partner Midwest Physician Anesthesia Svcs. Application Reader, Admissions Franklin & Marshall College Assistant Prof/Retired USN Rear Adm. Eastern Virginia Medical Schl Assistant. Director-Emergency Med. Spectrum Emergency Care Assembler Kelly Services Assistant Professor of Marine Science U.S. Coast Guard Academy Assistant Professor of Radiology Penn State/Hershey Med. Ctr. Assistant Managing Editor American Chemical Society Assistant Professor The College of New Jersey Assistant Professor Villanova University Assistant Professor of Chemistry Seton Hill University Assistant Professor of Chemistry St. Norbert College Assistant Professor/Pediatrician Tufts University Assistant State Health Officer Alabama Department of Public Health Assoc Dir Mgmt & Oper. Bureau Of Vet Medicine Associate Director-MRSEC Carnegie Mellon University Associate Director for Translational Medicine
    [Show full text]
  • Advancing Greater Philadelphia
    Advancing Greater Philadelphia > ANNUAL REPORT 2004 The Foundation effects change using a variety of tools appropriate to the issues facing Greater Philadelphia. With this annual report, we hope to build a better understanding ADVOCACY of our approaches to policy and systems change. CAPACITY COLLABORATION DEMONSTRATION EVIDENCE > ANNUAL REPORT 2004 Table of Contents 2 What We Do 4 Leadership Letter 7 Advancing Greater Philadelphia Through Policy and Systems Change 9 Advocacy 11 Capacity 13 Collaboration 15 Demonstration 17 Evidence 18 History of the Foundation 22 Founding Philosophies 24 Facts and Figures: Financial Highlights 28 Facts and Figures: Awards and Payments 30 Grant Awards: Arts & Culture 34 Grant Awards: Children, Youth, & Families 38 Grant Awards: Environment & Communities 44 Grant Awards: Opportunity Fund 45 Grant Awards: 50th Anniversary Grant 46 Members of the Corporation and Board of Directors 47 Foundation Staff >WHAT WE DO Foundation Programs The William Penn Foundation makes grants in three principal areas, guided by a strategic plan adopted in 2001. A fourth program evaluates the progress of our funding strategies and shares knowledge gained through our grantmaking. Artistic expression is a hallmark of a When all children and families have diverse, healthy region. Through our access to opportunity, society benefits. Arts & Culture program, we provide Our Children, Youth, & Families various types of core operating support program funds work in our region and planning grants for arts groups to promote a better early care and and cultural institutions, enabling them education system, more effective and to pursue their creative missions with equitable education policies, networks confidence in their organization’s future.
    [Show full text]
  • Quaker Chemical Corporation Announces Retirement of Dr
    Quaker Chemical Corporation Announces Retirement Of Dr. Edwin J. Delattre As Director After 30 Years Of Service And Appointment Of Mark A. Douglas As New Board Member January 31, 2013 CONSHOHOCKEN, Pa., Jan. 31, 2013 /PRNewswire/ -- Quaker Chemical Corporation (NYSE: KWR) today announced that, following nearly 30 years of meritorious service on the Board of Directors, Edwin J. Delattre has decided to retire upon completion of his current term as a Director at Quaker's annual meeting of shareholders in May of 2013. Michael F. Barry, Chairman, Chief Executive Officer and President, commented, "On behalf of Quaker, I want to thank Ed for his significant contributions and dedicated service over the years. He has been a valued member of the Board and we wish him the best in his retirement." Quaker also today announced the appointment on January 30, 2013 of Mark A. Douglas to Quaker's Board, effective immediately. Mr. Douglas is an officer of FMC Corporation (NYSE: FMC), a diversified chemical company serving agricultural, industrial and consumer markets globally with annual sales of approximately $3.4 billion. Mr. Douglas is currently President of FMC's Agricultural Products Group. He joined FMC in March 2010, as Vice President, Global Operations and International Development and as a member of the Executive Committee, and was named President, Industrial Chemicals Group in 2011. Mr. Douglas joined FMC from Dow Chemical where he was Vice President, President Asia, Dow Advanced Materials. Prior to joining Dow, Mr. Douglas was Corporate Vice President, President Asia, Rohm and Haas Company based in Shanghai. He previously served as Corporate Vice President, Director Procurement and Logistics for Rohm and Haas in Philadelphia.
    [Show full text]
  • American Pharma Congress
    American Pharma Congress Date & Venue: August 03-05, 2015 Philadelphia, USA (Theme: Scrupulous Knowledge of Pharmaceutical Science) Summary: American Pharma-2015 welcomes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions from all over the world. American Pharma-2015 is a specially designed cluster conference, which provides a deep, thorough knowledge of pharmaceutical education and current novel trends in pharmaceutical sciences with the theme of “Scrupulous knowledge of Pharmaceutical Sciences” which covers a wide range of critically important sessions. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the American Pharma-2015, where you will be sure to have a meaningful experience with scholars from around the world. All members of the American Pharma-2015 organizing committee look forward to meeting you in Philadelphia, USA. For more details please visit- http://american.pharmaceuticalconferences.com/ Importance & Scope: makers Rohm and Haas Company and FMC Corporation, pharmaceutical companies Wyeth and GlaxoSmithKline and Boeing Tremendous research was going on in the field of Pharmacy and Rotorcraft Systems. USA occupies a world’s top position in the scientific research. The products of our basic and applied scientific research not only provide us with high-quality jobs and support
    [Show full text]